Details for Patent: 9,649,352
✉ Email this page to a colleague
Which drugs does patent 9,649,352 protect, and when does it expire?
Patent 9,649,352 protects KIMYRSA and ORBACTIV and is included in two NDAs.
This patent has twelve patent family members in eleven countries.
Summary for Patent: 9,649,352
Title: | High purity oritavancin and method of producing same |
Abstract: | Drug substance preparations of oritavancin having high purity are disclosed, along with pharmaceutical compositions comprising such oritavancin drug substance preparations, and drug products or dosage forms comprising such pharmaceutical compositions. |
Inventor(s): | Rafai Far; Adel (Mount-Royal, CA), Krishna; Gopal (Parsippany, NJ), Ding; Min (Parsippany, NJ), Chemburkar; Sanjay R. (North Chicago, IL), Knable; Carl M. (North Chicago, IL), Petzel; James P. (North Chicago, IL), Pruyne; Julie J. (North Chicago, IL), Reamer; Douglas M. (North Chicago, IL) |
Assignee: | THE MEDICINES COMPANY (Parsippany, NJ) ABBVIE INC. (Chicago, IL) |
Application Number: | 14/801,303 |
Patent Claim Types: see list of patent claims | Composition; |
Drugs Protected by US Patent 9,649,352
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Melinta Therap | KIMYRSA | oritavancin diphosphate | POWDER;INTRAVENOUS | 214155-001 | Mar 12, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
Melinta Therap | ORBACTIV | oritavancin diphosphate | POWDER;INTRAVENOUS | 206334-001 | Aug 6, 2014 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,649,352
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2015289602 | ⤷ Sign Up | |||
Brazil | 112017000898 | ⤷ Sign Up | |||
Canada | 2955256 | ⤷ Sign Up | |||
China | 107206050 | ⤷ Sign Up | |||
Eurasian Patent Organization | 201700019 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |